Biological Imaging Reagents Market Analysis

Application (Clinical diagnostics, Drug discovery and development, Research and innovation, Other applications)

Clinical diagnostics segment in the biological imaging reagents market is purported to be the largest segment with a lucrative share of 42.3% as advanced diagnostic tools for early and accurate detection of diseases increase the demand. Imaging reagents are contrast agents used in MRI and CT scans or radiopharmaceuticals in PET scans. For instance, The FDA published a report in March 2024 stating the fact as of July 2023, that 692 AI-enabled medical devices had been approved for sale out of which 75% are used in the radiology field.

Imaging Modality (MRI, Ultrasound, X-ray and CT, Optical imaging, Nuclear imaging)

Advanced optical imaging tools such as sensitivity and resolution improvement continue to enhance optical imaging's usefulness in both research and clinical applications. Ongoing technological development along with expanding applications into drug discovery, disease diagnosis, and therapeutic monitoring are expected to trend the optical imaging segment further. The researchers seek novel solutions to monitor biological activities in real time. For example, GE HealthCare announced in November 2023 the launch of MyBreastAI suite, a platform of AI apps that helps with imaging workflows and breast cancer detection.

Our in-depth analysis of the biological imaging reagents market includes the following segments:

Product Type	Contrast reagents Optical reagents Nuclear reagents
Imaging Modality	MRI Ultrasound X-ray and CT Optical imaging Nuclear Imaging PET SPECT Other nuclear imaging modalities
End user	Hospitals Diagnostic imaging centers Research and academic institutes Pharmaceutical and biotechnology companies Other end users
Application	Clinical diagnostics Oncology Cardiology Neurology Other clinical diagnostic applications Drug discovery and development Research and innovation Other applications

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the biological imaging reagents market was over USD 13.3 billion.

The market size of the biological imaging reagents market is projected to cross USD 31.7 billion by the end of 2037 expanding at a CAGR of 7.5% during the forecast period i.e., between 2025-2037.

The major players in the market are Luminex Corporation, Nikon Corporation, Novartis AG, Olympus Corporation, Promega Corporation, Sartorius AG, and others.

In terms of application, the clinical diagnostics segment is anticipated to garner the largest market share of 42.3% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 33.7% by the end of 2037 and provide more business opportunities in the future.

Biological Imaging Reagents Market Analysis